Which ETFs hold Gilead Sciences Inc (GILD)?
American biotech company known for HIV, hepatitis and cancer treatments.
47 Australian ETFs hold Gilead Sciences Inc, a Health Care company from United States. DRUG has the biggest weighting at 2.91%. Across these funds, Australian ETF investors own about $457m of Gilead Sciences Inc.
The ETFs with the most Gilead Sciences Inc
All 47 ETFs that hold Gilead Sciences Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Gilead Sciences Inc.
Common questions
Which ETF has the most Gilead Sciences Inc?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 2.91% of the fund in Gilead Sciences Inc.
What is the cheapest ETF that holds Gilead Sciences Inc?
Of the ETFs where Gilead Sciences Inc is at least 1% of the fund, IXJ has the lowest fee at 0.41% a year, with 2.39% in Gilead Sciences Inc.
How much Gilead Sciences Inc do I own with $10,000 in VGS?
About $20. VGS is the largest ETF that holds Gilead Sciences Inc, and Gilead Sciences Inc makes up 0.20% of it.
How many Australian ETFs hold Gilead Sciences Inc?
47 ETFs listed on the ASX or TMX Australia hold Gilead Sciences Inc, based on issuers' published holdings.